Pria Foundation applications open on November 1, 2026. Two types of awards will be available to eligible grantees for the 2026–2027 cycle.
In support of early-stage projects
Year 1: up to $75,000
Year 2 (by approved renewal): up to $50,000
In support of established investigators for novel investigations
2 years, with a possible third year
Year 1: up to $250,000
Year 2: up to $350,000
Additional year renewal: up to $200,000
Based on competitive application, Scientific Advisory Board (SAB) review and recommendation to Trustees.
Particular consideration will be given to institutions and individual investigators who have not previously received major funding from Pria Foundation.
Funds not expended in a grant year may be rolled over with a request and justification submitted to the Scientific Advisory Board (SAB); upon SAB recommendation, the request is forwarded to the Trustees for decision.
A primary mentor with an active, independent research program is required for trainees and postdoctoral fellows and must submit a letter of support; a co-mentor may be included where relevant expertise spans disciplines.
Applicant must not currently hold a substantial independent research award as Principal Investigator (e.g., an NIH R01 or equivalent).
U.S. not-for-profit academic, medical, or research institution. A letter of institutional support is required.
Basic, translational, clinical, or population or implementation science research directly relevant to pancreatic cancer, feasible within a 1-year period.
All documents should conform to NIH guidelines for font type, size, line spacing, and margins.
U.S. not-for-profit academic, medical, or research institution.
Demonstrated record of independent extramural funding, or equivalent evidence of capacity to manage an award of this scale.
Multi-PI and multi-institutional teams are permitted and encouraged where complementary expertise strengthens the project.
Translational, clinical, or population-science research with clear near-term potential to affect patient care or outcomes.
Letter of Intent (due December 15, 2026)
Full Application (due March 1, 2027, by invitation only)
All documents should conform to NIH guidelines for font type, size, line spacing, and margins.
To apply for the Pilot grant:
To help our review team efficiently identify, organize, and process submissions, your email subject line must strictly follow this exact format: Pilot Grant Application: [Lead Researcher Last Name, First Name] - [Institution Name]; improperly formatted subject lines may cause your application to be misplaced or delayed.
In the body of your email, briefly include your research project title, the names and contact information for both the lead researcher and the primary institutional contact, and a statement confirming your PDF is attached. You will receive an automated confirmation email within 72 hours of your submission.
To submit a Letter of Intent for a Major Grant:
To help our review team efficiently identify, organize, and process submissions, your email subject line must strictly follow this exact format: Major Grant Letter of Intent: [Lead Researcher Last Name, First Name] - [Institution Name]; improperly formatted subject lines may cause your application to be misplaced or delayed.
In the body of your email, briefly include your research project title, the names and contact information for both the lead researcher and the primary institutional contact, and a statement confirming your PDF is attached. You will receive an automated confirmation email within 72 hours of your submission.
Applicants invited to submit a full application (due March 1, 2027) will receive submission instructions with their invitation.
